Today: 23 May 2026
Browse Category

NASDAQ:MGRX 13 November 2025 - 23 February 2026

Mangoceuticals stock slips before the bell after a 49% surge — what traders watch next for MGRX

Mangoceuticals stock slips before the bell after a 49% surge — what traders watch next for MGRX

Mangoceuticals shares fell about 4% to 51 cents in premarket trading Monday, easing after a 49% surge Friday that followed news of strong early sales for its $99-a-month testosterone therapy. Trading volume Friday spiked to 349 million shares. The company remains below Nasdaq’s $1 minimum bid requirement and has until August 3, 2026, to regain compliance.
23 February 2026
Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals announced partnerships with Eli Lilly and Novo Nordisk to offer official access to Zepbound and Wegovy through new telehealth programs, MangoRx Direct and PeachesRx Direct. Membership costs $99 per month, with GLP‑1 drugs starting at $499 monthly, no insurance required. MGRX shares jumped over 25% pre-market before retreating. The company recently settled a lawsuit with Lilly and reported a $10.3 million net loss.

Stock Market Today

  • NICE (TASE:NICE) Faces Valuation Question After 54% Share Decline
    May 23, 2026, 5:26 AM EDT. NICE, an AI-powered cloud platform company, has seen its share price fall 26% year to date and 54% over the past year despite reporting ₪3.0 billion in revenue and ₪529.6 million net income. The stock currently trades at ₪267.3, while analysts estimate a fair value of ₪620.96, suggesting the company may be undervalued amid strong AI-driven revenue growth and cloud adoption. However, risks include margin pressure from cloud investments and revenue churn from acquisitions. Investors are weighing near-term valuation concerns against NICE's long-term growth prospects in AI and customer engagement solutions.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 23.05.2026

23 May 2026
LIVEMarkets rolling coverageStarted: May 23, 2026, 4:00 AM EDTUpdated: May 23, 2026, 5:37 AM EDT NICE (TASE:NICE) Faces Valuation Question After 54% Share Decline May 23, 2026, 5:26 AM EDT. NICE, an AI-powered cloud platform company, has seen its share price fall 26% year to date and 54% over the past year despite reporting ₪3.0 billion in revenue and ₪529.6 million net income. The stock currently trades at ₪267.3, while analysts estimate a fair value of ₪620.96, suggesting the company may be undervalued amid strong AI-driven revenue growth and cloud adoption. However, risks include margin pressure from cloud investments and
Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

23 May 2026
The Dow closed at a record 50,579.70 on Friday, while the S&P 500 notched its eighth straight weekly gain. After-hours trading saw SPY, QQQ, DIA, and IWM all move lower. U.S. markets will be closed Monday for Memorial Day. Investors await Thursday’s inflation data.
Go toTop